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18.1 INTRODUCTION
Food allergy is an adverse, abnormal immune-mediated 
reaction to a certain food or food ingredient that appears in 
susceptible individuals, often requiring a strict avoidance of 
their ingestion (Amaya-González et al., 2013). Sometimes, 
people exhibit food sensitivity, including intolerance that 
is a nonimmune-mediated reaction. The incidence of these 
disorders is difficult to assess and the percentage of people 
self-perceived as food intolerant (up to 25%) is very dif-
ferent from that of confirmed cases (less than 3%). Most 
allergens are proteins that must be detected along the food 
chain, posing a real challenge for the development of ana-
lytical methods. Gliadin is a heat-stable allergen, known 
as the alcohol-soluble fraction of gluten, being the anti-
genic protein of wheat responsible for celiac disease. The 
ratio of gliadin to total gluten varies with the food matrix. 
The gliadin content usually corresponds to half of the glu-
ten content (Peres et al., 2011), although this value is not 
consensual (EFSA, 2004; Tranquet et al., 2012). A daily 
intake of 100 mg of gliadin can induce clinical symptoms in 
celiac patients, being the prevalence of celiac disease (clas-
sical, oligosymptomatic, and silent forms) in children and 
adults around 1:200 in Europe (EFSA, 2004). Therefore, 
a threefold definition of gluten-free foods was proposed 
(EFSA, 2004): (1) foods in which ingredients do not con-
tain any prolamin from wheat or Triticum species with a 
gluten level not exceeding 20 mg/kg (or ppm); (2) those 
consisting of ingredients which have been rendered “gluten-
free” with a gluten level not exceeding 200 mg/kg; and (3) 
those resulting from a mixture of ingredients with a gluten 
level not exceeding 200 mg/kg. It should be noticed that 
the values previously mentioned are only indicative since 
there is not enough information to make a final decision on 
them. More recently, foods labeled as “very low gluten” or 
“gluten-free” must have gluten content lower than 100 and 
20 mg/kg, respectively (Nassef et al., 2008; OJEU, 2009; 
Zeltner et al., 2009). However, commercial foods labeled as 
gluten-free may be contaminated by gluten in the range of 
20–200 ppm (Collin et al., 2004; Scognamiglio et al., 2014).
Several commercial analytical tools have been devel-
oped, namely to detect gliadin/gluten, most of them rely-
ing in immunoassays, both competitive for hydrolyzed 
food and sandwich formats for complete proteins (Amaya-
González et al., 2013). Moreover, emerging electrochemi-
cal techniques such as aptasensors and electronic tongues 
(e-tongues) have also been reported (Amaya-González 
et al., 2014; Meirinho et al., 2015; Peres et al., 2011).
18.2 GLIADINS AND THE CELIAC DISEASE
The celiac disease is classified as an autoimmune disease 
of the small intestine induced in genetically susceptible 
individuals that is caused by the ingestion of gluten pro-
teins, which are important components of commonly used 
food sources like wheat, rye, and barley (Bai et al., 2013; 
Shan et al., 2002). The introduction of gluten-rich foods in 
the human diet led to the development of disease related 
to gluten exposure (Sapone et al., 2012; Troncone and 
Jabri, 2011). These reactions are not restricted to celiac 
disease, but also include nonceliac gluten sensitivity and 
wheat allergy, which combined affect about 10% of the 
general population (Battais et al., 2003, 2005; Lammers 
et al., 2014; Williams et al., 2010; Woodward, 2010). More-
over, they represent distinct pathophysiological reactions to 
gluten ingestion, with differing clinical presentations, sero-
logical markers, and long-term treatments (Bai et al., 2013; 
Briani et al., 2008; Ciclitira et al., 2005b). Although current 
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research attempts to elucidate the frontiers between these 
reactions, their differences can be difficult to discriminate.
In the case of celiac patients, the exposure to gluten in-
duces an inflammatory response that ultimately will lead to 
the destruction of the villous structure of the intestine (Shan 
et al., 2002; Williams et al., 2010; Woodward, 2010). It 
usually appears in early childhood with pronounced symp-
toms such as chronic diarrhea, abdominal distension, and 
failure to thrive. In some patients, symptoms are only re-
vealed later in life and these may include fatigue, diarrhea, 
and weight loss due to malabsorption, anemia, and neuro-
logical symptoms (Ciclitira and Moodie, 2003). Celiac dis-
ease is a life-long disease and if untreated, it is associated 
with increased morbidity and mortality. Despite its high 
prevalence and severe symptoms, the only effective therapy 
is a strict dietary abstinence from the previously mentioned 
food grains (Briani et al., 2008; Fric et al., 2011; Tye-Din 
et al., 2010; Sapone et al., 2012).
Gluten is the main structural protein complex present 
in wheat with equivalent toxic proteins found in rye and 
barley (Sapone et al., 2012). The amino acid composition 
of gluten peptides with a high percentage of glutamine (up 
to 35%) and proline (15–20%) is unique (Fric et al., 2011). 
Immune-reactive protein fractions of gluten comprise glia-
dins and glutenins, with gliadins containing monomeric 
proteins and glutenins containing aggregated proteins 
(Bittner et al., 2008). Gliadins are complex glycoproteins 
rich in proline and glutamine (Lammers et al., 2014). Due 
to their structure, the intestinal enzymes cannot completely 
degrade the proteins. Actually, it is well known that undi-
gested or partly digested gliadins can affect a broad range of 
human cells (eg, inhibit cell growth, induce apoptosis, and 
alter redox equilibrium).
The celiac disease is a model autoimmune disease, in 
which, contrarily to many other autoimmune diseases, the 
trigger (gluten), the tight genetic junction (HLA antigens: 
DQ2 and DQ8), as well as the primary autoimmune reaction 
[autoantibodies to tissue transglutaminase (tTG)] are known 
(Fric et al., 2011; Sollid et al., 2012; Tye-Din et al., 2010). 
This knowledge represents an advantage in the development 
of new diagnosis and treatment methods, as well as for the 
development of food analytical techniques that can easily 
and accurately detect the presence of gluten-related toxic 
protein fractions, such as gliadins. Indeed, the main clinical 
issues in the management of celiac disease are that the di-
agnostics are suboptimal and invasive, and that patients 
must rely on a complex, costly, and life-long therapy (Tye-
Din et al., 2010). While intestinal biopsy is still considered 
the gold standard for diagnosing celiac disease, the pres-
ence of highly specific autoantibodies in patient serum has 
been clinically used as a marker for screening candidates 
for duodenal biopsy (Bizzaro et al., 2012; Ciclitira and 
Moodie, 2003; Williams et al., 2010; Woodward, 2010). 
Additionally, the relevance of antibody assessment in 
predicting celiac disease has increased along with the num-
ber of patients with minor or atypical symptoms.
As previously mentioned, from the human diseases re-
lated to gluten exposure, the best known are mediated by 
the adaptive immune system and include celiac disease and 
wheat allergy (Battais et al., 2003). In both conditions, the 
reaction to gluten is mediated by T-cell activation in the gas-
trointestinal mucosa (Han et al., 2013; Sapone et al., 2012). 
However, in wheat allergy, it is the cross-linking of immu-
noglobulin IgE by repeat sequences in gluten peptides that 
triggers the release of chemical mediators. Contrarily, the 
celiac disease is an autoimmune disorder as demonstrated 
by specific serologic autoantibodies [tTG and antiendomy-
sium antibodies (EMA)] (Han et al., 2013). Besides these 
two conditions, there are cases of gluten reactions in which 
neither allergic nor autoimmune mechanisms are involved. 
These are generally defined as gluten sensitivity. Individu-
als exhibiting gluten sensitivity are unable to tolerate glu-
ten and develop an adverse reaction different from the one 
observed in patients with celiac disease, that is, without 
damage in the small intestine (Bai et al., 2013; Troncone 
and Jabri, 2011). Although the symptoms may be similar to 
those associated with celiac disease, no tTG autoantibodies 
or other specific celiac-related antibodies are found.
Although a gluten-free diet is prescribed to patients 
suffering from diseases related to gluten exposure, this 
does not mean that they cannot tolerate gluten at all, as 
their clinical sensitivity varies significantly (Ciclitira 
et al., 2005a; Hischenhuber et al., 2005). Some individu-
als cannot tolerate trace amounts of gluten, whereas  others 
appear to tolerate large amounts. In the standard Western 
European gluten-free diet, some gluten is accepted as a 
contaminant in wheat starch (Kupper, 2005). This starch 
improves the baking quality and palatability of the gluten-
free diet and it is tolerated by most celiac patients (Collin 
et al., 2004; Fido et al., 1997; Goesaert et al., 2005; Peraaho 
et al., 2003). In other countries, such as United States of 
America, for example, wheat starch is not recommended. 
The US National Food Authority has decided that the  label 
“gluten-free” can only be used for foods that contain no 
gluten at all (Kupper, 2005). Therefore, foods that contain 
wheat starch should be labeled as “low-gluten” (Fasano and 
Catassi, 2001). The proposed standard as formulated by the 
WHO/FAO organization Codex Alimentarius, has one limit 
at 0.02% for “rendered gluten-free” food, and another at 
0.002% for “naturally gluten-free food” (Bai et al., 2013; 
Hischenhuber et al., 2005; Niewinski, 2008). These differ-
ent practices reflect the fact that we do not know the exact 
limit of gluten intake that is tolerated long term without 
harmful effects by patients with celiac disease as a group 
(Ciclitira et al., 2005a). The acceptable gluten dose per 
day is still under debate, although the scientific and medi-
cal communities have suggested that around 50 mg/day is 
safe (Hischenhuber et al., 2005). As a reference, the normal 
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gluten intake by healthy individuals is about 13 g/day (Van 
Overbeek et al., 1997). Research indicates no significant 
differences in susceptible individuals undergoing a strict 
wheat starch-containing, gluten-free diet versus a naturally 
gluten-free diet (Kupper, 2005).
In summary, the awareness of the gluten-related diseas-
es, its dietary restrictions, and the impact of adhering to a 
gluten-free diet warrant further research. Also, reliable de-
tection and quantification methods for food allergens, such 
as gluten proteins, are required to ensure compliance with 
food labeling and to improve consumer protection.
18.3 SENSOR DEVICES FOR GLIADIN 
AND/OR GLUTEN DETECTION IN FOODS
The availability of fast, sensitive, and reliable analytical 
methods to detect specific food risks, ensuring food safety 
for people susceptible or intolerant to some food substances 
that may be allergens like gliadins is of huge importance 
and a real need. Indeed, in a recently market survey carried 
out in the United States (Sharma et al., 2015), it was re-
ported that 3.6% of the gluten-free labeled foods evaluated 
contained 5.8–554 ppm of gluten, and 1.1% of those foods 
had gluten contents greater than the regulatory threshold 
(20 ppm). The limitations (eg, nonportability; strict operat-
ing conditions; and required highly qualified trained tech-
nicians) associated to the high-cost and time-consuming 
traditional methods (eg, gel or capillary electrophoresis, 
high-performance liquid chromatography, polymerase 
chain reaction) have encouraged the development of emerg-
ing sensor-based technologies. Nevertheless, it should be 
stated that those traditional techniques are complementary 
and sensitive tools that are commonly used to confirm the 
results of the immunological officially accepted methods 
(Rosell et al., 2014).
18.3.1 Factors Affecting Gliadins/Gluten 
Analysis
There are two issues that can make gluten analysis difficult, 
namely, the extraction yield of gliadin from the food samples 
and the use of a correct gliadin standard. These two factors 
may limit the development and/or implementation of novel 
analytical approaches for gluten-free food analysis (Rosell 
et al., 2014). Gluten extraction from processed foods is not 
an easy task, since, in some cases, during the food process-
ing, high temperatures are used that contribute to the forma-
tion of isopeptide bonds between amino and carboxamide 
groups of the protein residues or to the formation of protein 
aggregates making gluten analysis quite difficult. There-
fore, to ensure a complete extraction of both prolamins and 
glutenins, several cocktail recovery solutions have been 
proposed (Garcia et al., 2005; Mena et al., 2012), although 
some of them, namely those using b-mercaptoethanol, may 
be incompatible with some immunological-based tech-
niques. On the other hand, in gluten analysis, the use of the 
most adequate standard plays an important role. The stan-
dard should be as representative as possible of the gluten 
proteins to be analyzed. Some standards are available, such 
as The Working Group on Prolamin Analysis and Toxicity 
(PWG) gliadin standard (Van Eckert et al., 2006). Neverthe-
less, its use is not consensual. Some authors have suggested 
that it would be more correct to use a hydrolyzed standard 
combined with a competitive assay to quantify peptides of 
partially hydrolyzed gluten in fermented wheat, rye, and 
barley products (Comino et al., 2012, 2013;  Gessendorfer 
et al., 2009; Mena et al., 2012; Rosell et al., 2014).
Regardless of these pertinent questions, several works 
have reported the development of sensor-based analytical 
methodologies toward the detection of gliadins in food-
stuffs using commercial gliadin or gluten standards and ex-
traction approaches based on the use of aqueous–ethanolic 
solutions.
18.3.2 Immuno- and Aptasensors 
for Gliadin/Gluten Detection in Foods
In recent years, several optical and electrochemical 
biosensors, including immunosensors and aptasensors, have 
been developed to detect gliadin in food matrices, namely to 
evaluate gluten-free foods, since the amount of gluten must 
be lower than 20 mg/kg (or ppm), according to the legal 
requirements (Nassef et al., 2008; OJEU, 2009; Zeltner 
et al., 2009). De Stefano et al. (2006) used an optical sen-
sor with a recombinant glutamine-binding protein to detect 
traces of gluten in food. Nassef et al. (2008) proposed an 
electrochemical immunosensor, based on the use of an an-
tibody raised against the putative immunodominant celiac 
disease epitope, to measure the gliadin content in foods. De-
tection limits between 5.5 and 11.6 ng/mL (or ppb) could 
be achieved. Labelless impedimetric and antigliadin Fab-
based amperometric immunosensors were also developed 
by Nassef et al. (2009), showing gliadin detection limits of 
3.23 ng/mL. Mairal et al. (2009) developed a microfluo-
rimeter with a disposable polymer chip with a gliadin de-
tection limit of 4.1 ng/mL, by detecting the emission of a 
fluorophore-labeled monoclonal antigliadin antibody upon 
 excitation with light. Laube et al. (2011) developed an 
electrochemical magneto immunosensor, coupled or not to 
 ELISA, allowing the quantification of gliadin or small glia-
din fragments in natural or pretreated food samples with de-
tection limits ranging from 1.2 to 24.2 ng/mL (depending on 
the food matrix). Chu and Wen (2013) developed a sensitive 
liposomal fluorescence immunoassay with immunomag-
netic beads for the detection and quantification of gliadin 
in gluten-free foods with a detection limit of 0.6 mg/mL (or 
ppm), although slight cross-reactions with barley and rye 
were found. Although the immunosensor technology seems 
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promising, limitations like long-term stability, surface ef-
fects, and interferences resulting from complex sample 
matrices are major concerns (Neves et al., 2010). Also, 
finding a single antibody able to react with different glia-
din and glutenin subunits with similar affinity, as well as 
with prolamins from different cereals and from modified 
gluten is very challenging (Tranquet et al., 2012). Thus, due 
to the complexity of gluten proteins, the quantification of 
the total gluten content in foods is extrapolated from the 
gliadin concentration, assuming a constant gliadin–glutenin 
ratio equal to 1 within all samples (Tranquet et al., 2012). 
Gluten composition depends on multiple parameters such 
as the species, cultivars, agronomical conditions, as well 
as on the products processing (Wieser and Koehler, 2009). 
Therefore, some authors (Van Eckert et al., 2010; Wieser 
and Koehler, 2009) have suggested that the next step could 
be the use of a mixture of antibodies that could recognize 
gliadin and glutenin subunits at similar degrees. Still, the 
development of such assays, with two or more antibodies, 
is complex and may be expensive (Tranquet et al., 2012).
Hence, recently aptamers against hydrophobic immu-
notoxic peptides from gliadin from wheat that also recog-
nize celiac disease related proteins from barley, rye, and 
oat have been investigated (Amaya-González et al., 2013; 
Pinto et al., 2014). Fernández et al. (2012) developed an 
electrochemical genosensor for the detection of a specific 
DNA sequence that encodes an immunogenic fragment 
of gliadin, being achieved a detection limit of 0.001 mM. 
More recently, Amaya-González et al. (2014) reported a 
competitive electrochemical magneto-assay without cross-
reactivity with nontriggering celiac disease proteins from 
soya, rice, or maize. This device enabled the detection of 
0.5 ppb in diluted gliadin standard solutions, which corre-
sponds to a detection limit of 0.5 ppm of gluten, consider-
ing the dilution factor and assuming that gliadin constitutes 
50% of gluten.
18.3.3 Electronic Tongue
Although optical and electrochemical immuno- and aptas-
ensors proved to be a potentially fast and practical tool to 
accurately detect possible gliadin/gluten contamination of 
gluten-free labeled foods, their development has been very 
demanding, requiring a considerable amount of consum-
ables, equipment, and skilled technicians. A possible and 
simpler alternative has been proposed by Peres et al. (2011) 
and is based on the use of an all solid-state potentiomet-
ric e-tongue with 36 polymeric membranes, not coupled to 
any antibody against gliadin, or aptamer against any immu-
notoxic peptides from gliadin. The device comprised two-
sensor arrays, being the membranes prepared with organic 
compounds containing long carbon chain with different 
functional groups (lipid additive compounds). Each mem-
brane contained polyvinyl chloride (PVC) as polymeric 
matrix, a plasticizer, and a sensor additive. The multisen-
sor device enabled the semiquantitative discrimination of 
aqueous–ethanolic (30:70, v/v) mixtures, containing pre-
established levels of dissolved gliadin standard, chosen in 
order to mimic food aqueous–ethanolic extracts of gluten-
free, low-gluten content, or gluten-containing foodstuffs 
(<20; 20–200; and >200 mg/kg of gluten equivalent, as-
suming a gliadin/gluten ratio equal to 0.5) with a sensi-
tivity of around 80%, corresponding to a gliadin detection 
limit around 1–2 mg/kg. Also, e-tongue was successfully 
applied to real samples, being able to correctly classify 
more than 80% of the gluten-free or gluten-containing 
foodstuffs evaluated.
The successful performance reported by the research 
team (Peres et al., 2011) may be tentatively explained based 
on the chemical composition of the polymeric membranes 
applied on the e-tongue. Indeed, the lipid polymeric mem-
branes used contain hydrophobic and hydrophilic groups 
allowing the interaction with several chemical compounds 
(electrolytes and nonelectrolytes) via electrostatic or hy-
drophobic interactions (Kobayashi et al., 2010; Toyota 
et al., 2011a,b; Yasuura et al., 2014a,b). Hydrogen bonds 
or electrostatic interactions may also arise in the presence 
of mediating electrolyte substances, between carboxyl 
or phosphate groups in the lipid/polymer membrane and 
vicinal  hydroxyl groups of the target molecules (Toyota 
et al., 2011b). Furthermore, it is accepted that lipids in-
teract with proteins during gluten formation; thus, lipids 
could enhance the formation of large complex aggregates 
involving both gliadin and glutenin proteins (Carcea and 
 Schofield, 1996). Besides, it is known that nonpolar lip-
ids can be associated with glutenins through either hy-
drophobic interactions or hydrogen bonds, whereas polar 
lipids containing phosphate groups preferentially interact 
with gliadin (McCann et al., 2009). Moreover, when lipid/ 
polymer membranes are applied for protein detection, 
namely gliadin, that does not bind directly, it is expected 
that their behavior could mimic that of protein–lipid inter-
actions occurring in biological membranes, where unspe-
cific hydrophobic association or electrostatic interactions 
between protein and lipid head groups occur (Thomas and 
Glomset, 1999; Zhao and Lappalainen, 2012).
To further evaluate and verify the possible interaction of 
the lipidic membranes toward gliadin or gluten from wheat, 
a new e-tongue was built. The electrochemical device con-
sisted of a print-screen potentiometric array (Fig. 18.1), 
with 20 chemical sensors, with cross-sensitivity lipidic 
membranes and relative plasticizer-additive compositions 
(Table 18.1) identical to those previously used by the re-
search team for gliadin qualitative and semiquantitative 
detection (Peres et al., 2011). Plasticizer bis(2-ethylhexyl)
phthalate was replaced by dioctyl phenylphosphonate and 
the additives bis(2-ethylhexyl)phosphate and tridodecyl-
methylammonium chloride were not included in the new 
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electrochemical device tested, since in a preliminary study 
sensors containing those compounds showed low response 
toward gliadin and other proteins (data not shown). Final-
ly, each lipidic membrane contained PVC (≈32%), as the 
polymeric matrix, and a combination of each of the five 
plasticizers used (≈65%) and the four additive compounds 
(≈3%), as shown in Table 18.1. An identification code was 
used for each lipidic membrane, containing the letter S as 
the sensor followed by two numbers (the first identifying 
the plasticizer, from 1 to 5, and the latter the additive, from 
1 to 4) separated by a punctuation mark (comma).
The e-tongue signal profiles were recorded in alkaline 
aqueous–ethanolic solutions (pH≈12; 30:70 v/v) containing 
standard gliadin (from Sigma-Aldrich) or gluten (from 
Sigma-Aldrich, protein content >80%), varying from 
+86.1 to +151.0 mV and +82.7 to +142.4 mV, respectively. 
In general, for all sensors, the corrected signal poten-
tial ∆ = −E E E[ (mV) ]dissolved protein0 solvent0  increased with the [∆E(mV)=Edissolvedprotein0−Esolvent0]
FIGURE 18.1 Screen-printed scheme with conductive resin silver of the e-tongue multisensor device, containing 20 lipid/polymeric membranes, 
used for potentiometric analysis of aqueous–ethanolic gliadin or gluten standard solutions (surface isolated with acrylic resin).
TABLE 18.1 Sensors Used in the E-Tongue: Identification of the Plasticizer and Additive Compounds Used in Each 
Lipidic-Polymeric Membrane
ID No.a Name Chemical Formula
Plasticizer compoundb
1 Bis(1-butylpentyl) adipate [-(CH2)2COOCH[(CH2)3CH3]2]2
2 Dibutyl sebacate [-(CH2)4CO2(CH2)3CH3]2
3 2-Nitrophenyl-octyl ether O2NC6H4O(CH2)7CH3
4 Tris(2-ethylhexyl) phosphate [CH3(CH2)3CH(C2H5)CH2O]3P(O)
5 Dioctyl phenylphosphonate C6H5P(O)[O(CH2)7CH3]2
Additive compoundc
1 Octadecylamine CH3(CH2)17NH2
2 Oleyl alcohol CH3(CH2)7CH═CH(CH2)7CH2OH
3 Methyltrioctylammonium chloride [CH3(CH2)6CH2]3N(Cl)CH3
4 Oleic acid CH3(CH2)7CH═CH(CH2)7COOH
aSensor identification number.
bAll plasticizers were SelectophoreTM grade from Fluka, with purity ≥97%.
cAll additives were from Fluka, with purity ≥97%.
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gliadin or gluten content, because their responses evaluated 
in dynamic concentration ranges as can be seen in Fig. 18.2 
(gliadin: 10–1000 ppm; gluten: 15–1000 ppm).
Linear correlations were obtained by plotting the sen-
sors’ signals against decimal logarithm of the concentrations 
[∆E(mV) = a + b × log10 (C, ppm)], although for different 
concentration intervals (Table 18.2 and Fig. 18.3). All sen-
sors showed a quantitative response toward gliadin concen-
tration (0.967 ≤ R ≤ 0.997) enabling the quantification of 
gliadin in standard solutions. For more complex matrices, 
such as foodstuffs, the possible quantification of gliadin 
content must be experimentally evaluated, but it is expected 
that the use of multivariate regression models (linear or non-
linear) based on a subset of the most informative sensors 
(chosen using a heuristic or a metaheuristic variable selec-
tion algorithm) will overcome possible modeling difficul-
ties, namely due to signal interferences (Dias et al., 2014).
The results clearly show the capability of the e-tongue to 
quantify gliadin and, although only standard solutions were 
analyzed, a potential application to real samples can be fore-
seen. It should be noticed that, if gluten concentrations were 
converted into apparent gliadin contents (assuming a glia-
din–glutenin ratio equal to 1) similar regression equations 
would be obtained for the dependence of ∆E with log10(C), 
independently if the assays were made with gliadin or gluten 
solutions, as also exemplified in Fig. 18.3 for two e-tongue 
sensors (S1:4 and S4:4). This result suggests that, in prin-
ciple, the lipidic membranes are responding preferentially to 
gliadin over glutenin proteins. This apparent preference may 
be tentatively explained taking into account that: (1) glutenin 
has a greater average molecular weight (70–90 kDa) com-
pared to gliadin (30–50 kDa) (Wieser, 2008), which may 
favor the gliadin possible adsorption over glutenin and (2) 
lipidic membranes used preferentially interact with gliadin 
FIGURE 18.2 The e-tongue corrected signal profiles (∆E, mV) variation with increasing concentration levels of gliadin (10–1000 ppm) or gluten 
(15–1000 ppm) in aqueous–ethanolic standard solutions (pH≈12).
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over glutenin proteins due to their polarity and presence of 
a phosphate group in some of them (McCann et al., 2009). 
A more detailed analysis of the results, shown in Table 18.2, 
indicate that apparently the type of additive has less influ-
ence in the potentiometric signal responses than the type 
of plasticizer. Indeed, two plasticizers [tris(2-ethylhexyl) 
phosphate and dioctyl phenylphosphonate] gave the best 
correlations, which was expected due to the presence of the 
phosphate group that enhances the gliadin–lipid interaction 
(McCann et al., 2009).
Globally, from the results reported by Peres et al. (2011) 
and those obtained in this work, both based on the use of 
 potentiometric e-tongues with lipid/polymeric membranes, 
it can be inferred that this electrochemical approach ex-
hibits a sensitivity of 1–3 ppm (≈2–6 ppm of gluten), 
which is quite satisfactory since an analytical method 
with a sensitivity of 10 ppm is suitable for gluten detec-
tion (Zeltner et al., 2009). Moreover, the e-tongue fulfills 
the requirements of gluten-free, low-gluten content, or 
gluten-containing food label verification, enabling gliadin 
content quantification in a wide dynamic range, varying 
from 3 to 1000 ppm. However, this quantitative potential 
must be further investigated by applying the device to real 
food samples. Nonetheless, this work together with the pre-
vious one (Peres et al., 2011) may be viewed as a proof-of-
principle that a potentiometric e-tongue with lipidic mem-
branes may be used as a practical, fast, simple, and sensitive 
tool toward the detection of  gliadin.
18.4 CONCLUSIONS AND FINAL 
REMARKS
Several analytical techniques have been reported for gliadin 
detection in food samples. Recently, the use of sensors gained 
an increased attention, namely immunosensors and aptasen-
sors, which exhibit gliadin detection limits (3 ppb–0.6 ppm, 
depending on the technique) much lower than the regulatory 
gluten threshold allowed in gluten-free foodstuffs (<10 ppm 
of equivalent gliadin). Nevertheless, these high-sensitive 
techniques are usually far beyond the economic and techni-
cal possibilities of the majority of the food industries, namely 
micro- and small familiar enterprises, reducing its routine 
application. Hence, in recent years the research team has de-
veloped electrochemical devices for gliadin detection in food 
samples. The potentiometric e-tongues developed have exhib-
ited a suitable sensitivity toward gliadin (1–3 ppm) enabling 
TABLE 18.2 Parameters of the Linear-Logarithm Regressions and Dynamic Concentration Ranges for Each Sensor (S1:1 
to S5:4) of the Potentiometric E-Tongue [∆E(mV) = a + b × log10 (C, ppm)]
Sensor ID No.a
Gliadin Gluten
Concentration Range (ppm) Rb Concentration Range (ppm) Rb
S1:1 [10, 320] 0.967 [15, 570] 0.999
S1:2 [10, 320] 0.992 [15, 570] 0.995
S1:3 [10, 560] 0.997 [15, 1000] 0.993
S1:4 [10, 1000] 0.993 [15, 1000] 0.996
S2:1 [80, 1000] 0.991 [100, 820] 0.989
S2:2 [36, 1000] 0.994 [15, 1000] 0.996
S2:3 [80, 1000] 0.993 [15, 820] 0.96
S2:4 [36, 810] 0.996 [15, 820] 0.997
S3:1 [3, 810] 0.982 [15, 820] 0.990
S3:2 [3, 560] 0.997 [15, 820] 0.984
S3:3 [80, 1000] 0.992 [100, 820] 0.975
S3:4 [10, 560] 0.996 [15, 570] 0.825
S4:1 [10, 1000] 0.997 [190, 570] 0.991
S4:2 [10, 1000] 0.996 [190, 570] 0.974
S4:3 [3, 1000] 0.996 [190, 820] 0.994
S4:4 [10, 1000] 0.999 [190, 1000] 0.991
S5:1 [10, 1000] 0.995 [190, 1000] 0.960
S5:2 [36, 1000] 0.995 [190, 1000] 0.990
S5:3 [36, 1000] 0.994 [190, 1000] 0.984
S5:4 [36, 810] 0.993 [190, 1000] 0.979
aSensor identification code number based on the information given in Table 18.1.
bCorrelation coefficient.
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its quantification, as well as the qualitative or semiquantita-
tive discrimination of foods based on their gluten content and 
according to the legal thresholds. The satisfactory e-tongue 
performance suggests this device as a promising routine tool 
for gliadin detection in foodstuffs. Finally, the gliadin quan-
tification capability could be attributed to the polar character 
of the lipidic/polymeric membranes applied in the e-tongue, 
and also to the presence of the phosphate group in some of 
the membranes. Nevertheless, a wider study is required, in-
cluding the validation of the methodology using different 
liquid and food samples. Also, a future work should include 
the use of nonpolar lipidic membranes in the e-tongue since 
they preferentially interact with glutenins, enabling the direct 
quantification of the gluten content, thus avoiding the contro-
versial use of the gliadin–glutenin ratio equal to 1 to extrapo-
late the gluten concentration.
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